Most recently, it has been determined that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to some big range of endogenous opioids. As opposed to most opioid receptors, this receptor acts being a scavenger and does not activate… Read More